Systemic sclerosis
Authors:
- 1 December 2019
- journal article
- research article
- Published by Springer Nature in Die Innere Medizin
- Vol. 60 (12) , 1251-1267
Abstract
Systemic sclerosis (SSc) is a rare fibrosing rheumatic multi-systemic disease involving many medical specialties. The mortality of SSc is determined by lung fibrosis, pulmonary arterial hypertension and cardiac involvement. With early and intensive treatment, the disease can be stabilized and symptoms relieved. This review summarizes insights into pathophysiology, disease classification, clinical manifestations and successful therapies, as well as recent studies on new immunosuppressant, biological and vasoactive therapies.Keywords
This publication has 50 references indexed in Scilit:
- Digitale Ulzera bei systemischer Sklerose: Diagnostik und TherapieDMW - Deutsche Medizinische Wochenschrift, 2011
- The monoclonal anti-CD25 antibody basiliximab for the treatment of progressive systemic sclerosis: an open-label studyAnnals of the Rheumatic Diseases, 2011
- Involvement of functional autoantibodies against vascular receptors in systemic sclerosisAnnals of the Rheumatic Diseases, 2011
- Nutritional status as marker for disease activity and severity predicting mortality in patients with systemic sclerosisAnnals of the Rheumatic Diseases, 2010
- Causes and risk factors for death in systemic sclerosis: a study from the EULAR Scleroderma Trials and Research (EUSTAR) databaseAnnals of the Rheumatic Diseases, 2010
- Small intestinal bacterial overgrowth in systemic sclerosisRheumatology, 2009
- Autoantibodies and microvascular damage are independent predictive factors for the progression of Raynaud's phenomenon to systemic sclerosis: A twenty‐year prospective study of 586 patients, with validation of proposed criteria for early systemic sclerosisArthritis & Rheumatism, 2008
- Skin sclerosis is only of limited value to identify SSc patients with severe manifestations--an analysis of a distinct patient subgroup of the German Systemic Sclerosis Network (DNSS) RegisterRheumatology, 2008
- Scleroderma renal crisis: patient characteristics and long-term outcomesQJM: An International Journal of Medicine, 2007
- Cyclophosphamide versus Placebo in Scleroderma Lung DiseaseNew England Journal of Medicine, 2006